Get the Stockscreener App
0.2003
12.95%
-0.0325
Tc Biopharm Holdings Plc Adr stock is traded at $0.2003, with a volume of 883.82K.
It is down -12.95% in the last 24 hours and down -51.30% over the past month.
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.
See More
Previous Close:
$0.2328
Open:
$0.22
24h Volume:
883.82K
Relative Volume:
0.47
Market Cap:
$2.39M
Revenue:
$4.60M
Net Income/Loss:
$-6.25M
P/E Ratio:
-0.00284
EPS:
-70.6412
Net Cash Flow:
$-15.38M
1W Performance:
-45.39%
1M Performance:
-51.30%
6M Performance:
-92.62%
1Y Performance:
-97.31%
1-Day Range:
$0.20
$0.226
1-Week Range:
$0.20
$0.369
52-Week Range:
$0.20
$26.16
Tc Biopharm Holdings Plc Adr Stock (TCBP) Company Profile
Name
Tc Biopharm Holdings Plc Adr
Sector
Industry
Phone
01414337557
Address
MAXIM 1, HOLYTOWN
Compare TCBP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TCBP
Tc Biopharm Holdings Plc Adr
|
0.2003 | 2.39M | 4.60M | -6.25M | -15.38M | -70.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.36 | 123.91B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
715.63 | 78.94B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
650.90 | 39.98B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
274.84 | 35.89B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
118.71 | 28.75B | 3.30B | -501.07M | 1.03B | -2.1146 |
Tc Biopharm Holdings Plc Adr Stock (TCBP) Latest News
Check Out TC BioPharm (Holdings) plc ADR (TCBP)’s Trade Data Rather Than the Analysts’ Views - SETE News
TC BioPharm (Holdings) plc ADR (TCBP) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
TC Biopharm Faces Potential Nasdaq Delisting Due to Bid Price Non-Compliance - TipRanks
TC Biopharm Announces Special Stock Dividend and Temporary Trading Halt - TipRanks
TC BioPharm advances in acquisition strategy - Investing.com India
What Analysts Think About TC BioPharm (Holdings) plc ADR (NASDAQ: TCBP)’s Potential Raise - Stocks Register
TC BioPharm Approves Key Resolutions to Enhance Strategic Flexibility - TipRanks
No Stopping Argo Blockchain Plc ADR (NASDAQ: ARBK)’s Stock Plunged? - Stocks Register
NIO Inc ADR (NYSE: NIO) Stock Forecast: Could Pass $8 In A Year - Stocks Register
If You Don’t Buy Safe Pro Group Inc (NASDAQ: SPAI) Now, You’ll Regret It Later - Stocks Register
Would I Buy Opendoor Technologies Inc (NASDAQ: OPEN) Stock At Any Time In The Future? - Stocks Register
Tempest Therapeutics Inc (NASDAQ: TPST) Investors Should Be Worried About This. - Stocks Register
Where Do Analysts See Gamestop Corporation (NYSE: GME) Heading? - Stocks Register
TC BioPharm Advances Strategic Financial Initiative with New ADS Offering - TipRanks
TC BioPharm Announces Key Shareholder Meeting - TipRanks
TC Biopharm files $100M mixed securities shelf - TipRanks
TC Biopharm Faces Financial Strains Amid Rising Costs - TipRanks
TC Biopharm awarded funding of $250,000 from G-Rex Grant Program - TipRanks
TC BioPharm advances cancer therapy trials, raises $8M By Investing.com - Investing.com South Africa
TC BioPharm advances cancer therapy trials, raises $8M - Investing.com India
TC Biopharm refutes social media claim, remains compliant with Nasdaq rules - TipRanks
TC BioPharm denies Nasdaq delisting rumors - Investing.com
TC Biopharm enters research pact with Dr. Carlos Maluquer de Motes - TipRanks
United States shares mixed at close of trade; Dow Jones Industrial Average down 0.80% - Investing.com India
TC Biopharm (Holdings) PLC – ADR trading halted, volatility trading pause - TipRanks
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.80% - Investing.com
TCBP Stock Update: TC BioPharm (Holdings) plc ADR’s Banking’s Market Struggles and Potential Opportunities - The InvestChronicle
TC Biopharm announces artificial intelligene initiative with Carnegie Mellon - TipRanks
TCBP Announces Site Opening of Guys and St. Thomas Hospital - StockTitan
TC Biopharm announces first patient completes full dose regimen in ACHIEVE trial - TipRanks
TC BioPharm to start preclinical studies on monkeypox therapy - Investing.com India
TC Biopharm intends to launch preclinical study for treatment of Mpox - TipRanks
TC BioPharm to begin monkeypox treatment studies - Investing.com
TCBP’s Market Moves: -77.03% YTD Growth, -42.22% 6-Month loss, 68.52% in 30 Days - The InvestChronicle
TC BioPharm (Holdings) plc ADR (TCBP)’s stock rises to 7.28 per share - US Post News
TC Biopharm doses five new patients in the ACHIEVE Phase 2b trial in UK - TipRanks
TC Biopharm Unveils New Pre-Funded Warrant - TipRanks
Was there any good news for TC BioPharm (Holdings) plc ADR (TCBP) stock in the last session? - US Post News
Balance Sheet Insights: TC BioPharm (Holdings) plc ADR (TCBP)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
TC BioPharm secures European patent for cell therapy - Investing.com India
TC BioPharm Regains Nasdaq Compliance - TipRanks
TC BioPharm meets Nasdaq equity requirement - Investing.com
TC Biopharm Unveils Pre-Funded Share Warrants - TipRanks
TC BioPharm Regains Compliance with Nasdaq Listing Rule 5550(b) - StockTitan
TC BioPharm secures $2 million in direct offering - Investing.com
TC Biopharm Announces Warrant Adjustment - TipRanks
TC Biopharm At Risk of Nasdaq Delisting - TipRanks
Upcoming Stock Splits This Week (August 5 to August 9) – Stay Invested - Yahoo Finance
Tc Biopharm Holdings Plc Adr Stock (TCBP) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.51%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):